ABILIFY MAINTENA
Google image searchProduct monograph
Active ingredient
aripiprazole, 300 MG/VIAL
DIN: 02420864
Dosage form(s): POWDER FOR SUSPENSION, SUSTAINED-RELEASE, KIT
Route(s) of administration: INTRAMUSCULAR
Description: 200MG/ML AFTER RECONSTITUTION. SYRINGE AND DILUENT INCLUDED IN THE KIT
Schedule: Prescription
Company: OTSUKA PHARMACEUTICAL CO LTD
Date: 27-MAR-2014
ATC:
- N05 — PSYCHOLEPTICS (ATC, ATC/DDD, )
- N05A — ANTIPSYCHOTICS (ATC, ATC/DDD)
- N05AX — Other antipsychotics (ATC, ATC/DDD)
- N05AX12 — ARIPIPRAZOLE (ATC/DDD)
Reference brand drug: Abilify
Pharmaceutical standard: MFR
